Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype

Seminars in Cancer Biology

Volumn 22, Issue 5-6, 2012, Pages 379-384

  Medici, Damian ^a,b   Kalluri, Raghu ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

EMT; EndMT; Endothelial mesenchymal transition; Stem cells; TGF beta

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CD31 ANTIGEN; OSTEOGENIC PROTEIN 1; SMAD3 PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

BONE DISEASE; CANCER ASSOCIATED FIBROBLAST; CANCER STEM CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL TRANSFORMATION; DISEASE COURSE; EMBRYO DEVELOPMENT; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FIBROSIS; HETEROTOPIC OSSIFICATION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; REVIEW; STEM CELL; TUMOR CALCINOSIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; CELL TRANSDIFFERENTIATION; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; FIBROSIS; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASMS; PHENOTYPE;

EID: 84866336964     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2012.04.004     Document Type: Review

References (72)

1. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Current Opinion in Cell Biology 2003, 15:740-746.
2. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation 2009, 119:1420-1428.
3. Hay E.D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Developmental Dynamics 2005, 233:706-720.
4. Acloque H., Adams M.S., Fishwick K., Bronner-Fraser M., Nieto M.A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. Journal of Clinical Investigation 2009, 119:1438-1449.
5. Wynn T.A. Cellular and molecular mechanisms of fibrosis. Journal of Pathology 2008, 214:199-210.
6. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation 2003, 112:1776-1784.
7. Potenta S., Zeisberg E., Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. British Journal of Cancer 2008, 99:1375-1379.
8. Van Meeteren L.A., ten Dijke P. Regulation of endothelial cell plasticity by TGF-β. Cell and Tissue Research 2011, [Epub ahead of print].
9. Akhurst R.J., Derynck R. TGF-beta signaling in cancer-a double-edged sword. Trends in Cell Biology 2001, 11:S44-S51.
10. Medici D., Hay E.D., Olsen B.R. Snail and Slug promote epithelial-mesenchymal transition through β-catenin-TCF-4-dependent expression of TGF-β3. Molecular Biology of the Cell 2008, 19:4875-4887.
11. Romano L.A., Runyan R.B. Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. Developmental Biology 2000, 223:91-102.
12. Liebner S., Cattelino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., et al. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. Journal of Cell Biology 2004, 166:359-367.
13. Deissler H., Deissler H., Lang G.K., Lang G.E. TGFbeta induces transdifferentiation of iBREC to alphaSMA-expressing cells. International Journal of Molecular Medicine 2006, 18:577-582.
14. Tavares A.L., Mercado-Pimentel M.E., Runyan R.B., Kitten G.T. TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Developmental Dynamics 2006, 235:1589-1598.
15. Kokudo T., Suzuki Y., Yoshimatsu Y., Yamazaki T., Watabe T., Miyazono K. Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. Journal of Cell Science 2008, 121:3317-3324.
16. Azhar M., Runyan R.B., Gard C., Sanford L.P., Miller M.L., Andringa A., et al. Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Developmental Dynamics 2009, 238:431-442.
17. Medici D., Shore E.M., Lounev V.Y., Kaplan F.S., Kalluri R., Olsen B.R. Conversion of vascular endothelial cells into multipotent stem-like cells. Nature Medicine 2010, 16:1400-1406.
18. Medici D., Potenta S., Kalluri R. Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochemical Journal 2011, 437:515-520.
19. Boyer A.S., Ayerinskas I.I., Vincent E.B., McKinney L.A., Weeks D.L., Runyan R.B. TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Developmental Biology 1999, 208:530-545.
20. Camenisch T.D., Molin D.G., Person A., Runyan R.B., Gittenberger-de Groot A.C., McDonald J.A., et al. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Developmental Biology 2002, 248:170-181.
21. Mercado-Pimentel M.E., Runyan R.B. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells, Tissues, Organs 2007, 185:146-156.
22. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine 2007, 13:952-961.
23. Moonen J.R., Krenning G., Brinker M.G., Koerts J.A., van Luyn M.J., Harmsen M.C. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovascular Research 2010, 86:506-515.
24. Lebrin F., Goumans M.J., Jonker L., Carvalho R.L., Valdimarsdottir G., Thorikay M., et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO Journal 2004, 23:4018-4028.
25. Lebrin F., Deckers M., Bertolino P., ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovascular Research 2005, 65:599-608.
26. Wrana J.L., Attisano L., Weisner R., Ventura F., Massague J. Mechanism of activation of the TGF-β receptor. Nature 1994, 370:341-347.
27. Sridurongrit S., Larsson J., Schwartz R., Ruiz-Lozano P., Kaartinen V. Signaling via the Tgf-β type I receptor Alk5 in heart development. Developmental Biology 2008, 322:208-218.
28. Kang M.H., Kang H.N., Kim J.L., Kim J.S., Oh S.C., Yoo Y.A. Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion. Oncology Reports 2009, 22:525-534.
29. Molloy E.L., Adams A., Moore J.B., Masterson J.C., Madrigal-Estebas L., Mahon B.P., et al. BMP4 induces an epithelial-mesenchymal transition-like response is adult airway epithelial cells. Growth Factors 2008, 26:12-22.
30. Ma L., Lu M.F., Schwartz R.J., Martin J.F. BMP2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005, 132:5601-5611.
31. McCulley D.J., Kang J.O., Martin J.F., Black B.L. BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development. Developmental Dynamics 2008, 237:3200-3209.
32. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
33. Wang J., Sridurongrit S., Dudas M., Thomas P., Nagy A., Schneider M.D., et al. Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Developmental Biology 2005, 286:299-310.
34. Paruchuri S., Yang J.H., Aikawa E., Melero-Martin J.M., Khan Z., Loukogeorgakis S., et al. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circulation Research 2006, 99:861-869.
35. Peinado H., Portillo F., Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. International Journal of Developmental Biology 2004, 8:365-375.
36. Medici D., Hay E.D., Goodenough D.A. Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Molecular Biology of the Cell 2006, 17:1871-1879.
37. Nawhsad A., Medici D., Liu C.C., Hay E.D. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF-1 transcription complex. Journal of Cell Science 2006, 120:1646-1653.
38. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
39. Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nature Cell Biology 2004, 6:931-940.
40. Lee J.G., Kay E.P. FGF-2-mediated signal transduction during endothelial mesenchymal transformation in corneal endothelial cells. Experimental Eye Research 2006, 83:1309-1316.
41. Chang A.C., Fu Y., Garside V.C., Niessen K., Chang L., Fuller M., et al. Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Developmental Cell 2011, 21:288-300.
42. Valles A.M., Boyer B., Tarone G., Thiery J.P. Alpha 2 beta 1 integrin is required for the collagen and FGF-1 induced cell dispersion in a rat bladder carcinoma cell line. Cell Adhesion and Communication 1996, 4:187-199.
43. Medici D., Nawshad A. Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1. Matrix Biology 2010, 29:161-165.
44. Shintani Y., Fukumoto Y., Chaika N., Svoboda R., Wheelock M.J., Johnson K.R. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. Journal of Cell Biology 2008, 180:1277-1289.
45. Walsh L.A., Nawshad A., Medici D. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Matrix Biology 2011, 30:243-247.
46. Morgan M.R., Byron A., Humphries M.J., Bass M.D. Giving off mixed signals-distinct functions of alpha5beta1 and alphavbeta3 integrins in regulating cell behaviour. IUBMB Life 2009, 61:731-738.
47. Markwald R.R., Fitzharris T.P., Smith W.N. Structural analysis of endocardial cytodifferentiation. Developmental Biology 1975, 42:160-180.
48. Lee S.B., Kalluri R. Mechanistic connection between inflammation and fibrosis. Kidney International. Supplement 2010, 119:S22-S26.
49. Frangogiannis N.G. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflammation Research 2004, 53:585-595.
50. Kizu A., Medici D., Kalluri R. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. American Journal of Pathology 2009, 175:1371-1373.
51. Zeisberg E.M., Potenta S.E., Sugimoto H., Zeisberg M., Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American Society of Nephrology 2008, 19:2282-2287.
52. Li J., Qu X., Bertram J.F. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. American Journal of Pathology 2009, 175:1380-1388.
53. Li J., Qu X., Yao J., Caruana G., Ricardo S.D., Yamamoto Y., et al. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 2010, 59:2612-2624.
54. Hashimoto N., Phan S.H., Imaizumi K., Matsuo M., Nakashima H., Kawabe T., et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology 2010, 43:161-172.
55. Fukumura D., Jain R.K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. Journal of Cellular Biochemistry 2007, 101:937-949.
56. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Research 2007, 67:10123-10128.
57. Higgins D.F., Kimura K., Iwano M., Haase V.H. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008, 7:1128-1132.
58. Reynolds A.M., Holmes M.D., Danilov S.M., Reynolds P.N. Targeted gene delivery of BMPR-2 attenuates pulmonary hypertension. The European Respiratory Journal 2011, [Epub ahead of print].
59. Lu X., Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clinical Cancer Research 2010, 16:5928-5935.
60. Jiang J., Tang Y.L., Liang X.H. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biology and Therapy 2011, 11:714-723.
61. Davis G.E., Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circulation Research 2005, 97:1093-1107.
62. Medici D., Olsen B.R. Transforming blood vessels into bone. Cell Cycle 2011, 10:362-363.
63. Shore E.M., Kaplan F.S. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 2008, 43:427-433.
64. Kaplan F.S., Shen Q., Lounev V., Seemann P., Groppe J., Katagiri T., et al. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). Journal of Bone and Mineral Metabolism 2008, 26:521-530.
65. Shore E.M., Xu M., Feldman G.J., Fenstermacher D.A., Cho T.J., Choi I.H., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nature Genetics 2006, 38:525-527.
66. Shen Q., Little S.C., Xu M., Haupt J., Ast C., Katagiri T., et al. Fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. Journal of Clinical Investigation 2009, 119:3462-3472.
67. Lounev V.Y., Ramachandran R., Wosczyna M.N., Yamamoto M., Maidment A.D., Shore E.M., et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. Journal of Bone and Joint Surgery (American Volume) 2009, 91:652-663.
68. Dudley A.C., Khan Z.A., Shih S.C., Kang S.Y., Zwaans B.M., Bischoff J., et al. Calcification of multipotent prostate tumor endothelium. Cancer Cell 2008, 14:201-211.
69. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circulation Research 2005, 97:512-523.
70. Perivascular cells expressing annexin A5 define a novel mesenchymal stem cell-like population with the capacity to differentiate into multiple mesenchymal lineages. Development 2005, 132:2657-2668.
71. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
72. Gupta P.B., Chaffer C.L., Weinberg R.A. Cancer stem cells: mirage or reality?. Nature Medicine 2009, 15:1010-1012.